13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-07-31 Event 2024-10-01 SEC 0001683168-26-005875 →

ExcelFin SPAC LLC Baird Medical Investment Holdings Ltd BDMDW

Stake: 19.10% Shares: 4,249,031 CUSIP: G0705H103 Class: Ordinary Shares, par value $0.0001 per share

Item 4 — Purpose of Transaction

The Reporting Persons acquired the securities of the Issuer for investment purposes. Depending on market conditions, the Issuer's financial position and strategic direction, and other factors, each Reporting Person may from time to time acquire additional securities of the Issuer or dispose of some or all of the securities of the Issuer that it beneficially owns, in the open market, in privately negotiated transactions, or otherwise. The Reporting Persons may engage in discussions with the Issuer's management and board of directors regarding the Issuer's business, operations, capitalization, corporate governance, strategic transactions (including financings, asset sales, mergers or other business combinations), and other matters relating to the Issuer. Except as set forth in this Item 4, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions enumerated in Item 4 of Schedule 13D.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 8.21
2,168 shares short · 0.0% vs prior

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →